Psychosis News and Research

RSS

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''

Substance use common in young mental health patients

Young people using mental healthcare services have a high frequency of alcohol, nicotine, and cannabis use, Australian study results show.

15 Feb 2013

Substance use common in young mental health patients

Young people using mental healthcare services have a high frequency of alcohol, nicotine, and cannabis use, Australian study results show.

15 Feb 2013

Nightmare of insomnia could explain suicide link in patients with depression

The link between insomnia and suicidal thoughts in patients with depression may be mediated by nightmares and dysfunctional beliefs and attitudes about sleep, research suggests.

15 Feb 2013

Familial psychosis risk linked to prefrontal dopamine dysfunction

People at familial risk for psychosis have attenuated dopamine stress modulation in the ventromedial prefrontal cortex, according to a recent in vivo imaging study.

8 Feb 2013

Parental psychosis affects early schizophrenia risk factors

Parental psychosis alters the impact that individual biological risk factors during pregnancy and birth have on future schizophrenia risk, say Finnish researchers.

7 Feb 2013

Migraine, epilepsy and genetics: an interview with Dr. Melodie Winawer

This work is the product of an extraordinary consortium called the Epilepsy Phenome/Genome project (EPGP). It is a consortium of 27 centres in the U.S. and internationally with several hundred physicians and staff who have worked together to enrol more than 4000 patients with epilepsy and their family members.

7 Feb 2013

Ethnicity strongly linked to treatment resistance in schizophrenia

Patients with schizophrenia are at heightened risk for being resistant to treatment if they are White European, study findings reveal.

6 Feb 2013

Senate hearing urges action on Obama mental health care agenda

Democrats and Republicans expressed concerns about gaps in the system at the Senate Health, Education, Labor and Pensions Committee.

28 Jan 2013

Adolescent declines in cognitive performance predict later psychosis

Adolescents and young adults experiencing relative declines in cognitive performance have an increased risk for later psychosis, with a decline in verbal ability between 13 and 18 years of age a strong predictor, conclude researchers.

25 Jan 2013

Tell tale neurologic soft signs for schizophrenia and bipolar disorder

Neurologic soft signs can differentiate schizophrenia from major depression but not bipolar disorder, study findings indicate.

22 Jan 2013

Psychiatrist claims medical marijuana dangerous for treatment of psychiatric problems

Using medical marijuana to treat conditions such as anxiety and depression is dangerous and has no basis in medical science, says Dr. Timothy R. Jennings, a prominent Tennessee psychiatrist and consultant to The Center for Counseling and Health Resources in Edmonds, WA.

22 Jan 2013

Biophysical Society Annual Meeting to highlight innovations in medicine, physics, and more

Honeybee silk-inspired materials; a deconstruction of the Ebola virus; how microbes evolve resistance to antibiotics; and a possible connection between Alzheimer's disease and type II diabetes are just some of the intriguing topics that will be presented at the 57th Annual Meeting of the Biophysical Society (BPS).

22 Jan 2013

Dopamine synthesis increased in patients at high risk for psychosis

UK study results show that patients at ultra-high risk for psychosis have elevated dopamine synthesis capacity in the dorsal striatum.

17 Jan 2013

MPAs may reflect genetic risk for schizophrenia

Minor physical anomalies are more common in schizophrenia patients and their unaffected siblings than in mentally healthy individuals without a family history of the disorder, research shows.

16 Jan 2013

Fifteen established scientists to receive NARSAD Distinguished Investigator Grants

The Brain & Behavior Research Foundation (formerly NARSAD, the National Alliance for Research on Schizophrenia and Depression) announced the latest recipients of its highly competitive NARSAD Distinguished Investigator Grants.

16 Jan 2013

Reviva Pharmaceuticals completes enrollment in RP5063 phase 2 trial for schizophrenia

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announces completion of patient enrollment in the phase 2 clinical trial of RP5063 for the treatment of schizophrenia and schizoaffective disorder.

16 Jan 2013

Vanderbilt University, AstraZeneca partner to identify candidate drugs for major brain diseases

Today, AstraZeneca and Vanderbilt University announced they have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer's disease and schizophrenia.

16 Jan 2013

Patients with Parkinson's develop artistic talents after dopamine-inducing therapy

Parkinson's experts across the world have been reporting a remarkable phenomenon - many patients treated with drugs to increase the activity of dopamine in the brain as a therapy for motor symptoms such as tremors and muscle rigidity are developing new creative talents, including painting, sculpting, writing, and more.

16 Jan 2013

Pfizer’s Quillivant XR now available in the U.S. for treatment of ADHD

Pfizer Inc. today announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of attention deficit hyperactivity disorder (ADHD).

16 Jan 2013